Nothing ever really works how you expect it will. So you need to be able to adjust without necessarily changing your view. That way, you can succeed even if obstacles get in your way.
In profile
A counterpointed career
My academic past and investment present strike a contrast.
Before joining Baillie Gifford, I turned back time on animal cells – literally reprogramming them to resemble their embryonic form and studying how proteins interacted with DNA during the transition. After nearly a decade’s work, Nature published the University of Edinburgh study. The research may have been more academic than applied, but could eventually help combat disease by giving scientists a deeper understanding of how it arises at the cellular level.
In essence, I reversed the ageing process – the opposite of my role today: accelerating private companies’ progress by providing them with capital. Timescales differ, too. As investors, we dedicate time to building relationships with founders, but working in weeks rather than years suits everyone: the entrepreneurs, our clients – and my temperament.
Endurance and uncertainty
What my two careers have in common, however, is longevity. Just as I hope others build on my PhD research to ultimately extend lives, my intent at Baillie Gifford is to help companies endure.
Likewise, both involve a high degree of uncertainty. You never know in science whether an experiment will validate your theory or set you on a new path. The parallel for long-term investors is that we can’t predict every setback or opportunity a company will face. But to tilt the odds in our favour, I gravitate towards companies that think hard about resilience and have scalability, laying the foundations for their second act even as they focus on the first. You can’t always anticipate what will come next, but adaptability increases a company’s chances of success.
Location
Edinburgh
Favourite book
Hans Rosling: Factfulness
Important information
Baillie Gifford Overseas Limited provides investment management and advisory services to non-UK clients and is authorised and regulated by the UK Financial Conduct Authority. Baillie Gifford Overseas Limited is not licensed under the Regulation of Investment Advising, Investment Marketing and Portfolio Management Law, 5755-1995 (the “Advice Law”) and does not carry insurance pursuant to the Advice Law.
Baillie Gifford Overseas Limited markets and distributes Baillie Gifford’s range of collective investment schemes to Qualified Clients and Qualified Investors in Israel, as listed in the First Addendum to the Regulation of Investment Advising, Investment Marketing and Portfolio Management Law, 5755-1995 (the “Advice Law”) and in the First Addendum to the Israel Securities Law, 5728-1968 (the “Securities Law”). Detailed disclosure of the collective investment schemes can be found within this website and in the relevant scheme prospectus.
Baillie Gifford Overseas Limited does not provide investment advice. If you are in any doubt about whether an investment is suitable, you should seek independent advice.
No action has been or will be taken in Israel that would permit a public offering or distribution of the Funds mentioned in this website to the public in Israel. This website and the Funds mentioned herein have not been approved by the Israeli Securities Authority (the “ISA”). In addition, the Funds mentioned in this website are not regulated under the provisions of Israel’s Joint Investment Trusts law, 5754-1994 (the “Joint Investment Trusts Law”). This website and the Funds mentioned herein will only be distributed to Israeli residents in reliance on an exemption from any advice or marketing restrictions [in a manner that will not constitute “an offer to the public” under sections 15 and 15a of]/[in reliance on an exemption from the prospectus requirements under] the Israel Securities Law, 5728-1968 (the “Securities Law”) or the Joint Investment Trusts Law, and any guidelines, pronouncements or rulings issued from time to time by the ISA as applicable.